Keyuan Pharmaceutical: Shareholders ask Zehong and Jiang Chunmei to complete a 1% reduction in holdings

K-LinePoet · 2026-04-06T07:17:48+00:00

Keyuan Pharmaceutical Announcement: Shareholder Wen Zehong and the concerted action person Jiang Chunmei's reduction plan has been completed. Wen Zehong originally planned to reduce no more than 1.08M shares, accounting for 1.00% of the total share capital, through centralized bidding within three months after the disclosure of the announcement. From February 10 to February 13, 2026, at 35.33 yuan per share, they reduced 282.7k shares; from March 10 to March 11, 2026, at 44.3 yuan per share, they reduced 800.2k shares, totaling 1.08M shares, accounting for 1.0000% of the total share capital. After the reduction, Wen Zehong holds 4.33M shares, accounting for 4.00%, and Jiang Chunmei holds 282.7k shares, accounting for 0.26%.

K-LinePoet

2026-04-06 07:17:48

Keyuan Pharmaceutical Co., Ltd. announcement: The shareholding reduction plan of Qun Zehong, a shareholder holding more than 5%, and his concerted-action party, Jiang Chunmei, has been completed. Qun Zehong originally planned to, within 3 months after the 15th trading day from the date of announcement, reduce his holdings by no more than 1.0829 million shares through centralized competitive bidding, representing 1.00% of the total share capital. From 2026.2.10 to 2026.2.13, he reduced 0.2827 million shares at 35.33 yuan/share; from 2026.3.10 to 2026.3.11, he reduced 0.8002 million shares at 44.3 yuan/share; the total reduction was 1.0829 million shares, representing 1.0000% of the total share capital. After the reduction, Qun Zehong holds 4.3316 million shares, representing 4.00%, and Jiang Chunmei holds 0.2827 million shares, representing 0.26%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.